161 related articles for article (PubMed ID: 10426589)
1. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors.
Sugitani I; Fujimoto Y
Endocr J; 1999 Feb; 46(1):209-16. PubMed ID: 10426589
[TBL] [Abstract][Full Text] [Related]
2. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes.
Sugitani I; Toda K; Yamada K; Yamamoto N; Ikenaga M; Fujimoto Y
World J Surg; 2010 Jun; 34(6):1222-31. PubMed ID: 20066418
[TBL] [Abstract][Full Text] [Related]
3. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
5. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience [corrected].
Al-Qahtani KH; Al Asiri M; Tunio MA; Aljohani NJ; Bayoumi Y; Fatani H; AlHadab A
J Otolaryngol Head Neck Surg; 2015 Dec; 44():51. PubMed ID: 26621255
[TBL] [Abstract][Full Text] [Related]
7. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
8. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience.
Cappelli C; Castellano M; Braga M; Gandossi E; Pirola I; De Martino E; Agosti B; Rosei EA
J Surg Oncol; 2007 Jun; 95(7):555-60. PubMed ID: 17226813
[TBL] [Abstract][Full Text] [Related]
9. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
11. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
12. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.
Ghossein R; Ganly I; Biagini A; Robenshtok E; Rivera M; Tuttle RM
Thyroid; 2014 Feb; 24(2):245-53. PubMed ID: 23745671
[TBL] [Abstract][Full Text] [Related]
14. [Treatment strategy for patients with papillary microcarcinoma].
Sugitani I; Fujimoto Y; Yamada K
Nihon Rinsho; 2007 Nov; 65(11):2045-8. PubMed ID: 18018568
[TBL] [Abstract][Full Text] [Related]
15. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
16. Papillary microcarcinoma of the thyroid.
Shaha AR; Tuttle RM; Shah JP
J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
[No Abstract] [Full Text] [Related]
17. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature.
Garrel R; Tripodi C; Cartier C; Makeieff M; Crampette L; Guerrier B
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Jun; 128(3):115-9. PubMed ID: 21333620
[TBL] [Abstract][Full Text] [Related]
18. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
Leboulleux S; Rubino C; Baudin E; Caillou B; Hartl DM; Bidart JM; Travagli JP; Schlumberger M
J Clin Endocrinol Metab; 2005 Oct; 90(10):5723-9. PubMed ID: 16030160
[TBL] [Abstract][Full Text] [Related]
20. Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Londero SC; Krogdahl A; Bastholt L; Overgaard J; Trolle W; Pedersen HB; Bentzen J; Schytte S; Christiansen P; Godballe C;
Thyroid; 2013 Sep; 23(9):1159-64. PubMed ID: 23427917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]